EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment

Jacob Gadwa, Justin Yu, Miles Piper, Michael W Knitz, Laurel B Darragh, Nicholas Olimpo, Sophia Corbo, Jessica I Beynor, Brooke Neupert, Alexander T Nguyen, Chloe Hodgson, Diemmy Nguyen und 8 weitere

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2024-010405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Jacob Gadwa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment with immunotherapy can elicit varying responses across cancer types, and the mechanistic underpinnings that contribute to response vrsus progression remain poorly understood. However, to date there are few preclinical models that accurately represent these disparate disease scenarios.

Methods

Using combinatorial radio-immunotherapy consisting of PD-1 blockade, IL2Rβγ biased signaling, and OX40 agonism we were able to generate preclinical tumor models with conflicting responses, where head and neck squamous cell carcinoma (HNSCC) models respond and pancreatic ductal adenocarcinoma (PDAC) progresses.

Results

By modeling these disparate states, we find that regulatory T cells (Tregs) are expanded in PDAC tumors undergoing treatment, constraining tumor reactive CD8 T cell activity. Consequently, the depletion of Tregs restores the therapeutic efficacy of our treatment and abrogates the disparity between models. Moreover, we show that through heterotopic implantations the site of tumor development defines the response to therapy, as implantation of HNSCC tumors into the pancreas resulted in comparable levels of tumor progression.

Conclusions

This work highlights the complexity of combining immunotherapies within the tumor microenvironment (TME) and further defines the immune and non-immune components of the TME as an intrinsic feature of immune suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentAnimalsMiceHumansImmunotherapyCarcinoma, Pancreatic DuctalPancreatic NeoplasmsSquamous Cell Carcinoma of Head and NeckCell Line, TumorFemale

Stichwörter der Autor:innen

Head and Neck CancerImmunotherapyRadiotherapy/radioimmunotherapyT cellT regulatory cell - Treg

Autor:innen und Institutionen

  • Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Otolaryngology - Head & Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Roche Innovation Centre Zurich, Schlieren, Switzerland.
  • Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA sanadkaram@wustl.edu.

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research
  • National Cancer Institute

Zitieren

APA

Gadwa, J., Yu, J., Piper, M., Knitz, M. W., Darragh, L. B., Olimpo, N., Corbo, S., Beynor, J. I., Neupert, B., Nguyen, A. T., Hodgson, C., Nguyen, D., Abdelazeem, K. N., Saviola, A., Pousse, L., Bransi, A., Pincha, M., Klein, C., Amann, M., & Karam, S. D. (2025). Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010405

Vancouver

Gadwa J, Yu J, Piper M, Knitz MW, Darragh LB, Olimpo N, et al. Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2024-010405

BibTeX
@article{Gadwa2025,
  author = {Gadwa, Jacob and Yu, Justin and Piper, Miles and Knitz, Michael W and Darragh, Laurel B and Olimpo, Nicholas and Corbo, Sophia and Beynor, Jessica I and Neupert, Brooke and Nguyen, Alexander T and Hodgson, Chloe and Nguyen, Diemmy and Abdelazeem, Khalid Nm and Saviola, Anthony and Pousse, Laurene and Bransi, Ali and Pincha, Mudita and Klein, Christian and Amann, Maria and Karam, Sana D},
  title = {Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2024-010405}
}
Kostenlos starten →